Faculty who hold an Investigational New Drug or Investigational Device Exemption must fulfill the responsibilities of both a sponsor and an investigator. Known as a sponsor-investigator, this is an individual who both initiates and conducts an investigation, and under whose immediate direction the investigational drug or device is administered or dispensed. Unique obligations of a sponsor-investigator include routine monitoring to assure regulatory and protocol compliance and to confirm that data are accurate, complete, and verifiable.
Contact Us for more information or to request a free consultation.
UW Principal Investigators (PI’s) may contract with the CMS to monitor the progress of FDA-regulated, investigators-initiated clinical trials, and verify that the study is conducted, recorded, and reported in accordance with the protocol, standard operating procedures, and applicable regulatory requirements.
The CMS follows standard operating procedures and detailed monitoring plans written in conjunction with the investigator and tailored to the unique needs of a trial. Fees are determined based on study complexity and frequency of monitoring. Monitors conduct study initiation, routine monitoring and close-out visits to ensure:
The following compliance services are also available per request:
CMS Program Manager
Kristen is a Certified Clinical Research Professional (CCRP). She serves as the Manager of the CMS after joining UW-Madison in January of 2021. Kristen is passionate about teaming up with investigators and study teams to promote and enhance research compliance across campus.
Program Coordinator, CMS & FDA Regulated Research Oversight Program
Aimee is the Program Coordinator in the CMS and the FDA Regulated Research Oversight Program, a joint venture between the Institute for Clinical & Translational Research (ICTR) and the UW Office of the Vice Chancellor for Research and Graduate Education that serves to promote and verify regulatory compliance in FDA-regulated research at UW-Madison.